PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 9, 20260 citationsOpen Access

Development of targeted immunomodulatory VLPs to enhance antigen presentation and potentiate the antitumor immune response

View Full Paper
TNThiago NatividadeMBMárcio Bajgelman

Key Points

  • The aim is to develop targeted immunomodulatory virus-like particles (VLPs) to improve antigen presentation and stimulate the antitumor immune response.
  • Development of virus-like particles (VLPs) targeting specific antigens.
  • Assessment of immune responses in preclinical tumor models.
  • Evaluation of antigen presentation efficacy and immune activation.
  • Improved antigen presentation observed in treated models.
  • Significant enhancement of antitumor immune response measured via specific immune cell activation.
  • Potential for VLPs to serve as effective immunotherapies for tumors.

Abstract

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Natividade et al. (2026) studied this question.

synapsesocial.com/papers/69fece83b9154b0b82875edchttps://doi.org/10.35259/isi.2026_76210
Ask AI
Helpful
Bookmark
Share
View Full Paper